INTEGRA LIFESCIENCES HOLDING (IART) Stock News
NASDAQ:IART - Nasdaq - US4579852082 - Common Stock - Currency: USD
IART Latest News, Press Relases and Analysis
Is the Options Market Predicting a Spike in Integra LifeSciences Stock?
Investors need to pay close attention to Integra LifeSciences stock based on the movements in the options market lately.
Enbridge Is One of the Largest Energy Companies by Market Cap. But Is It a Buy?
Enbridge still has incredible competitive advantages. According to new research from The Motley Fool, Enbridge (NYSE: ENB), one of the biggest pipeline operators in the world, is now also one of the largest publicly traded energy companies. For years, investors have relied on the company for its juicy dividend, which now delivers a yield of nearly 6%.
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: VCYT
Integra (IART) Up 2.3% Since Last Earnings Report: Can It Continue?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: TFX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:...
IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:...
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut
IART's first-quarter 2025 earnings lag the consensus mark. Q2 revenue projections are bleak.
Integra LifeSciences Reports First Quarter 2025 Financial Results
PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...